Owners, management and financials
CVR: 38655590
Previous names: GlyProVac IVS, Boysen Bio IVS
DKK -4,142
Gross profit
Net result: DKK -4,142
Anders Boysen (100%)
CVR · view owners
Anders Boysen
CVR · view management
Active
Founded 21 May 2017
CVR · view overview
0 employees
Annual report 2025 · average
Name registered: Boysen Bio ApS
CVR · 01/10/2021
View the full event history
Boysen Bio ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Boysen Bio IVS and GlyProVac IVS. The management consists of Anders Boysen. The company is owned by Anders Boysen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,142 and a net result of DKK -4,142 compared with DKK -4,968 the year before. Equity in the 2025 report amounted to DKK 42,055.
Selskabets formål er at eje aktier og anparter samt enhver i forbindelse hermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/07/2024 – 30/06/2025 | -4K | -4K | 319K | 42K | 0 | |
| 202401/07/2023 – 30/06/2024 | -5K | -5K | 316K | 46K | - | |
| 202301/07/2022 – 30/06/2023 | -5K | -5K | 257K | 51K | - | |
| 202201/07/2021 – 30/06/2022 | -5K | -5K | 376K | 56K | - | |
| 202101/07/2020 – 30/06/2021 | -4K | -4K | 782K | 21K | - | |
| 202001/07/2019 – 30/06/2020 | -4K | -4K | 942K | 25K | - | |
| 201901/07/2018 – 30/06/2019 | -9K | -18K | 498K | 29K | - |
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of Boysen Bio ApS is 38655590.
Boysen Bio ApS is owned by Anders Boysen.
The management of Boysen Bio ApS consists of Anders Boysen.
In 2025, Boysen Bio ApS reported a gross profit of DKK -4,142.
Boysen Bio ApS had an average of 0 employees in the 2025 financial year according to the annual report.
Boysen Bio ApS was founded on 21 May 2017.
Claim this page to add your logo and social links. Free to get started.
Boysen Bio ApS has published its annual report for 2025. Gross profit came to DKK -4,142, and the net result was DKK -4,142.
Boysen Bio ApS has published its annual report for 2024. Gross profit came to DKK -4,968, and the net result was DKK -4,968.
Boysen Bio ApS has published its annual report for 2023. Gross profit came to DKK -5,105, and the net result was DKK -5,110.
Boysen Bio ApS has published its annual report for 2022. Gross profit came to DKK -5,014, and the net result was DKK -5,062.
Boysen Bio ApS has published its annual report for 2021. Gross profit came to DKK -4,382, and the net result was DKK -4,039.
On October 1, 2021, the company changed its name from Boysen Bio IVS to Boysen Bio ApS.
Boysen Bio ApS has published its annual report for 2020. Gross profit came to DKK -4,270, and the net result was DKK -3,598.
Boysen Bio ApS has published its annual report for 2019. Gross profit came to DKK -8,610, and the net result was DKK -17,696.
Boysen Bio ApS has published its interim report for the period May 21, 2017 to June 30, 2018.
On June 19, 2018, the company changed its name from GlyProVac IVS to Boysen Bio IVS.
As of May 21, 2017, Anders Boysen is registered as adm. dir. of Boysen Bio ApS.
As of May 21, 2017, Anders Boysen is registered as an owner of Boysen Bio ApS with an ownership share of 100%.
Boysen Bio ApS was founded on May 21, 2017.
Companies in the same industry and area
CVR 30197860
CVR 35141316
CVR 34883874
CVR 39990741
CVR 31186242
